Search for Clinical Trial Results

Sponsored By

Langerhans Cell Histiocytosis - 25 Studies Found

Status Study
Recruiting Study Name: Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Date: 2015-04-18
Interventions: Drug: Clofarabine Evaluation of response to clofarabine
Recruiting Study Name: LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Date: 2014-07-07
Interventions:
  • Drug: Prednisone Stratum I
Completed Study Name: Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Condition: Childhood Langerhans Cell Histiocytosis
Date: 2006-01-12
Interventions:
  • Drug: leucovorin calcium
  • Drug: methotrexat
Completed Study Name: Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function
Condition: Pulmonary Langerhans Cell Histiocytosis
Date: 2012-07-25
Recruiting Study Name: Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Date: 2015-02-09
Interventions: Drug: methotrexate Single Group Assignment Other Nam
Recruiting Study Name: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Condition: Langerhans Cell Histiocytosis
Date: 2016-01-04
Interventions:
  • Drug: Cytarabine Cytarabine 10
Recruiting Study Name: Characterization of Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytoses
Date: 2017-03-23
Recruiting Study Name: Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Date: 2016-01-14
Recruiting Study Name: A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Date: 2011-07-12
Interventions: Drug: GSK2110183 Drug will be administered as 125 mg capsules once daily.
Recruiting Study Name: Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
Condition: Pulmonary Langerhans Cell Histiocytosis
Date: 2017-02-09
Next >>>